Shocking HIV-1 with immunomodulatory latency reversing agents.

Kula-Pacurar, Anna; Rodari, Anthony; Darcis, Gilles; Van Lint, Carine

Kula-Pacurar, Anna; Rodari, Anthony; Darcis, Gilles; Van Lint, Carine.

Affiliation

Kula-Pacurar A; Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland. Electronic address: anna.kula-pacurar@uj.edu.pl.
Rodari A; Service of Molecular Virology, Department of Molecular Virology (DBM), Université Libre de Bruxelles (ULB), Gosselies, Belgium.
Darcis G; Infectious Diseases Department, Liège University Hospital, Liège, Belgium.
Van Lint C; Service of Molecular Virology, Department of Molecular Virology (DBM), Université Libre de Bruxelles (ULB), Gosselies, Belgium. Electronic address: cvlint@ulb.ac.be.

Semin Immunol ; 51: 101478, 2021 01.

Article in En | MEDLINE | ID: mdl-33972164

Subject(s)

HIV Infections; HIV-1; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes/metabolism; HIV Infections/drug therapy; HIV-1/physiology; Humans; Virus Activation; Virus Latency

Key words

HIV; Immunomodulatory latency reversing agents; Molecular mechanisms; Shock-and-kill

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 Limits: Humans Language: En Journal: Semin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google